News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Galenea Signs Collaboration And License Agreement With Otsuka Pharmaceutical Co., Ltd.


10/19/2005 5:12:44 PM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 16, 2005--On January 8, 2005, Galenea Corp. signed a research and development collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. to discover novel pharmaceuticals for the treatment of central nervous system (CNS) diseases, including schizophrenia and bipolar disorder. The parties' collaboration includes an equity investment in Galenea by Otsuka Pharmaceutical.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES